Clinical Trial Update: A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AHB-137 in healthy participants and in individuals with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137

Snippet

Sponsor: AusperBio Therapeutics Inc. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED